SCHEMBL768982

SCHEMBL768982

O=C(O)C1CCNc2ccccc21

nearest known ligand 0.54

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.54
F12 P00748 16/20 0.46
F2 P00734 4/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30020668 1.00 ALDH1A1 (0.54) ALDH1A1F12F2
SCHEMBL30899479 1.00 ALDH1A1 (0.54) ALDH1A1F12F2
SCHEMBL8909276 0.90 ALDH1A1 (0.49) ALDH1A1F12
SCHEMBL7377538 0.90 ALDH1A1 (0.51) ALDH1A1F12
SCHEMBL30899467 0.84 F12 (0.48) F12F2
SCHEMBL30899466 0.84 F12 (0.48) F12F2
SCHEMBL1906311 0.84 F12 (0.48) F12F2
Hydrochloric Acid SCHEMBL30899457 0.83 F12 (0.47) F12F2
Hydrochloric Acid SCHEMBL29279631 0.83 F12 (0.47) F12F2
SCHEMBL5800011 0.81 ALDH1A1 (0.57) ALDH1A1F2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 133 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250197690-A1 ANAEROBICALLY CURABLE COMPOSITIONS HENKEL AG & CO KGAA (DE) 2025-06-19 US claimed
US-20240052219-A1 ANAEROBICALLY CURABLE COMPOSITIONS HENKEL AG & CO KGAA (DE) 2024-02-15 US claimed
US-11891512-B2 Redox curable compositions and methods of manufacture thereof HENKEL AG & CO. KGAA (DE) 2024-02-06 US claimed
US-20230147662-A1 REDOX CURABLE COMPOSITIONS AND METHODS OF MANUFACTURE THEREOF HENKEL AG & CO. KGAA (DE) 2023-05-11 US claimed
US-20230113686-A1 ANAEROBICALLY CURABLE COMPOSITIONS HENKEL AG & CO KGAA (DE) 2023-04-13 US claimed
EP-4127014-A1 REDOX CURABLE COMPOSITIONS AND METHODS OF MANUFACTURE THEREOF Henkel AG & Co. KGaA (DE) 2023-02-08 EP claimed
CN-115427475-A Oxidizable-reducing curing composition and preparation method thereof 汉高股份有限及两合公司 2022-12-02 CN claimed
CN-115362192-A Anaerobically curable compositions 汉高股份有限及两合公司 2022-11-18 CN claimed
WO-2021197931-A1 REDOX CURABLE COMPOSITIONS AND METHODS OF MANUFACTURE THEREOF Henkel IP & Holding GmbH (DE) 2021-10-07 WO claimed
EP-2049493-A2 COMPOUNDS SUITABLE AS MODULATORS OF HDL Cadila Healthcare Limited (IN) 2009-04-22 EP claimed
CN-1561215-A Salts of substituted 1,2,3,4-tetrahydroquinoline-2-carboxylic acid compounds used as nmda antagonist GRUENENTHAL GMBH (DE) 2005-01-05 CN claimed
CN-1130346-C Tetrahydroquinolines as NMDA antagonists GLAXO WELLCOME SPA (IT) 2003-12-10 CN claimed
CN-1311785-A Tetrahydroquinoline derivatives as glycine antagonists GLAXO WELLCOME SPA (IT) 2001-09-05 CN claimed
CN-1060679-C Use of combination of angiotensin-converting enzyme inhibitor and calcium antagonist for treatment of proteinuria HOECHST MEDICINE DEUTSCHLAND A (DE) 2001-01-17 CN claimed
CN-1055472-C Oxazoloquinolinone derivatives, their preparation and their therapeutic use SYNTHELABO (FR) 2000-08-16 CN claimed
CN-1257482-A Quinoline-2-carboxylic acid derivative and its use as excitatory amino acids antagonist GLAXO WELLCOME SPA (IT) 2000-06-21 CN claimed
EP-0914332-A1 ISOQUINOLINES USEFUL AS ANALGESICS Astra Aktiebolag (SE) 1999-05-12 EP claimed
CN-1202887-A Tetrahydroquinolines as NMDA antagonists GLAXO WELLCOME SPA (IT) 1998-12-23 CN claimed
WO-1997031940-A1 ISOQUINOLINES USEFUL AS ANALGESICS ASTRA AKTIEBOLAG (SE) 1997-09-04 WO claimed
CN-1128763-A Oxazoloquinolinone derivatives, their preparation and their therapeutic use SYNTHELABO (FR) 1996-08-14 CN claimed